Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study.
Monika RaethkeFlorence van HunselNicoletta LuxiThomas LieberChiara BellittoErik MulderFrancesco CiccimarraFabio RiefoloNicolas H ThurinDebabrata RoyKathryn MortonFelipe VillalobosFrancisco Batel MarquesAndreea FarcasSimona SonderlichováSvetlana BelitserOlaf KlungelGianluca TrifiròMiriam C SturkenboomPublished in: Vaccine (2024)
Despite some limitations due to study design and study-roll out, CEM studies can allow prompt and almost real-time observations of the safety of medications directly from a patient-centered perspective, which can play a crucial role for regulatory bodies during an emergency setting such as the COVID-19 pandemic.